Skip to main content
SpringerLink
Log in

Que penser des polémiques récentes sur le dépistage organisé des cancers du sein ?

Thoughts on the recent controversies regarding scheduled breast cancer screening

  • Actualités de la SFSPM / SFSPM News
  • Les pages de la SFSPM
  • Published:
Oncologie

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Références

  1. Allgood PC, Duffy SW, Kearing O, et al. (2011) Explaining the difference in prognosis between screen detected and symptomatic cancers. Br J Cancer 104: 1680–1685

    Article  PubMed  CAS  Google Scholar 

  2. Autier P, Boniol M, Middleton R, et al. (2011) Advanced breast cancer incidence following population based mammographic screening. Ann Oncol 22: 1726–1735

    Article  PubMed  CAS  Google Scholar 

  3. Bleyer A, Welch G (2012) Effects of three decades of screening mammography on breast cancer incidence. NEJM 367: 1998–2005

    Article  PubMed  CAS  Google Scholar 

  4. Bouée S, Grosclaude P, Alfonsi A, et al. (2010) Projection of the incidence of breast cancer in France in 2018. Bull Cancer 97(3): 293–299

    PubMed  Google Scholar 

  5. Cabut S (2011) Cancer du sein: le dépistage en examen. Le Monde, Supplément santé, Science et techno, 22 octobre

    Google Scholar 

  6. EUROSCREEN Working Group (2012) J Med Screen 19(Suppl 1): 5–72

    Google Scholar 

  7. Gathion S, Lançon F, Viguier J, Mazeau-Woynar V (2011) Y a-t-il une augmentation des mastectomies totales ? Évolution des pratiques de chirurgie pour cancer du sein en France entre 2005 et 2009. Forum de dépistage, 33es Journées de la SFSPM, Marseille, novembre 2011, pp. 208–211

    Google Scholar 

  8. Gøtzsche PC, Nielsen M (2011) Screening for breast cancer with mammography. Cochrane Database Syst Rev (1):CD001877 — http://www.cochrane.org (accés mars 2013)

    Google Scholar 

  9. HAS (2011) Participation au dépistage organisé du cancer du sein. Recommandations en santé publique, novembre

    Google Scholar 

  10. Hendrick RE, Helvie MA (2012) Mammography screening: a new estimate of number needed to screen to prevent one breast cancer death. AJR Am J Roentgenol 198(3): 723–728

    Article  PubMed  Google Scholar 

  11. Inca (2012) Éthique et dépistage organisé du cancer du sein. Rapport du GRED

    Google Scholar 

  12. Independent UK Panel on Breast Cancer Screening (2012) The benefits and harms of breast cancer screening: an independent review. Lancet 380(9855): 1778–1786

    Article  Google Scholar 

  13. Jorgensen KJ, Keen J, Gotzsche P (2011) Is mammography screening justifiable considering its substantial overdiagnosis rate and minor effects on mortality? Radiology 260: 621–627

    Article  PubMed  Google Scholar 

  14. Junod B, Zahl PH, Kaplan RM, et al. (2011) An investigation of the apparent breast cancer epidemic in france: screening and incidence trends in birth cohorts. BMC Cancer 11: 401–407

    Article  PubMed  Google Scholar 

  15. Kalager M, Adami H, Bretthauer M, et al. (2012) Overdiagnosis of invasive breast cancer due to mammography screenin: results from norvegian screening program. Ann Intern Med 256: 491–499

    Article  Google Scholar 

  16. Kalager M, Zelen M, Langmark F, Adami HO (2010) Effect of screening mammography on breast-cancer mortality in Norway. N Engl J Med 363(13): 1203–1210

    Article  PubMed  CAS  Google Scholar 

  17. Kerlikowske K, Grady D, Rubin SM, et al. (1995) Efficacy of screening mammography. A meta-analysis. JAMA 273(2): 149–154

    Article  PubMed  CAS  Google Scholar 

  18. Nelson H, Tyne K, Naik A, et al. (2009) Screening for breast cancer: an update for the US preventive Task Force. Ann Intern Med 151: 716–726

    Article  Google Scholar 

  19. Olsen O, Gøtzsche PC (2001) Cochrane review on screening for breast cancer with mammography. Lancet 358(9290): 1340–1342

    Article  PubMed  CAS  Google Scholar 

  20. Que choisir. Octobre 2012, no 507: 24–29

  21. Rogel A, Lastier D, Salines E (2012) Évaluation du programme national de dépistage organisé du cancer du sein en France: période 2004–2009. BEH 399–404, 35.36.37 sept, pp 399–407

    Google Scholar 

  22. Tabar L, Vitak B, Hsiu-Hsi Chen, et al. (2011) Swedish two county trail: impact of mammographic screenong on breats cancer mortality during three decades. Radiology 260(3): 658–664

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Département d’imagerie, Centre Régional de Lutte Contre le Cancer Oscar Lambret, F-59000, Lille, France

    L. Ceugnart & S. Taieb

  2. ARCADES, Parc Mure, Batiment A, 16, Bd des Aciéries, F-13910, Marseille, France

    B. Séradour

  3. Axular radiologie, Centre le Futura, 62 avenue de Bayonne, F-64600, Anglet, France

    B. Barreau

Authors
  1. L. Ceugnart
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. B. Séradour
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S. Taieb
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. B. Barreau
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to L. Ceugnart.

About this article

Cite this article

Ceugnart, L., Séradour, B., Taieb, S. et al. Que penser des polémiques récentes sur le dépistage organisé des cancers du sein ?. Oncologie 15, 343–345 (2013). https://doi.org/10.1007/s10269-013-2297-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10269-013-2297-3

Search

Navigation